SCHEMBL24317331

SCHEMBL24317331

CSC1(C)CCCN(Cc2ccccc2S(=O)(=O)N2CCOCC2)C1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 2/20 0.42
CYP2D6 P10635 6/20 0.42
CYP3A4 P08684 5/20 0.42
TSHR P16473 3/20 0.42
NPC1 O15118 1/20 0.38
CYP1A2 P05177 1/20 0.37
OPRM1 P35372 1/20 0.37
OPRK1 P41145 1/20 0.37
ALDH1A1 P00352 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP2A13 Q16696 2/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26620040 0.87 PTGDR2 (0.47) PTGDR2CYP2D6CYP3A4TSHRNPC1
SCHEMBL24317328 0.87 PTGDR2 (0.44) PTGDR2CYP2D6CYP3A4TSHRNPC1
SCHEMBL26620037 0.85 PTGDR2 (0.43) PTGDR2CYP2D6CYP3A4TSHRNPC1
SCHEMBL24315786 0.85 CYP2D6 (0.44) PTGDR2CYP2D6CYP3A4TSHRNPC1
SCHEMBL26620044 0.83 CYP2D6 (0.46) PTGDR2CYP2D6CYP3A4TSHRNPC1
SCHEMBL27010239 0.83 PTGDR2 (0.42) PTGDR2CYP2D6CYP3A4TSHRNPC1
SCHEMBL26620334 0.82 PTGDR2 (0.48) PTGDR2CYP2D6CYP3A4TSHRNPC1
SCHEMBL24316060 0.81 PTGDR2 (0.48) PTGDR2CYP3A4TSHRNPC1ALDH1A1
SCHEMBL26620324 0.81 PTGDR2 (0.45) PTGDR2CYP2D6CYP3A4TSHRNPC1
SCHEMBL24315785 0.80 PTGDR2 (0.42) PTGDR2CYP2D6CYP3A4TSHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081927-A1 TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed